A Zhu, A Srivastava, J Ibrahim, R Patro, M Love, MM Love 2020 Impact of adherence to ibrutinib on clinical outcomes in real-world patients with chronic lymphocytic leukemia

Anqi Zhu, Donglin Zeng, Li Shen, Xia Ning, Lang Li, and Pengyue Zhang. A super‐combo‐drug test to detect adverse drug events and drug interactions from electronic health records in the era of polypharmacy. Statistics in Medicine, February 2020. doi.org/10.1002/sim.8490

ACM Transactions on Multimedia Computing, Communications, and Applications …

‪Duke-NUS Medical School‬ - ‪‪Cited by 26‬‬

2024年6月19日 · View a PDF of the paper titled Part-aware Unified Representation of Language and Skeleton for Zero-shot Action Recognition, by Anqi Zhu and 3 other authors

Lead the development of the statistical analysis workflow of bulk and single-cell amplicon-seq data for validating a CRISPR base editing technique-based platform for accelerated drug resistant variant discovery. The co-first author manuscript is published on Cell Reports.

I am currently a statistician and bioinformatician at Genentech OMNI Bioinformatics department. In 2019-2021, I was a scientist of computational biology at 23andMe Therapeutics. I also serve as one of the organizers of the Bay Area Biotech-Pharma Statistics (BBSW) Meetups since 2020.

Anqi Zhu via Scopus - Elsevier Acute Myeloid Leukemia with Co-mutated ASXL1 and SRSF2 Exhibits Monocytic Differentiation and has a Mutational Profile Overlapping with Chronic Myelomonocytic Leukemia HemaSphere

Specifically I am building predictive modeling based on genetic information, comparing and combining genetic signals from multiple ethnicities, and incorporating genomics information to understand...

Statistician in Bioinformatics team @Genentech. Former Computational Biologist @23andMe. PhD of Biostatistics from the University of North Carolina Chapel Hill. Prevent this user from interacting with your repositories and sending you notifications. Learn more about blocking users.